4//SEC Filing
Wood Gavin 4
Accession 0001104659-25-087085
CIK 0001621227other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:00 PM ET
Size
6.2 KB
Accession
0001104659-25-087085
Insider Transaction Report
Form 4
Wood Gavin
Chief Financial Officer
Transactions
- Sale
Ordinary Shares with a nominal value of GBP0.001 per share
2025-09-02$0.01/sh−96,000$950→ 0 total
Footnotes (4)
- [F1]The ordinary shares whose sale is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by the Reporting Person. Each ADS represents six ordinary shares of the Issuer.
- [F2]The 96,000 ordinary shares reported in Column 4 are represented by 16,000 ADSs.
- [F3]The price reported in Column 4 of $0.0099 per ordinary share is derived from the sale price of $0.0594 per ADS divided by six. These ADSs were sold in multiple transactions at a price of $0.0594. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission with full information regarding the ADSs sold at this price in this footnote.
- [F4]The Reporting Person does not hold any ordinary shares in the form of ADSs following this transaction. However, the Reporting Person holds nominal cost options and other options covering an aggregate of 11,140,760 ordinary shares of the Issuer.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001577539
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 5:00 PM ET
- Size
- 6.2 KB